← All companies

INO

Inovio Pharmaceuticals, Inc.

INO Nasdaq Pharmaceutical Preparations EDGAR ↗

$0.70

+0.02 +2.50%

Key statistics

from XBRL data in SEC filings

Market cap

$57.3M

Revenue (TTM)

$0.00

Net income (TTM)

-$85.0M

EPS (TTM)

$-1.58

P/E ratio

—

Dividend yield

—

Free cash flow

-$88.9M

Cash

$26.3M

Total assets

$49.8M

Gross margin

—

52-week range

$0.56 – $2.98

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Entered a material agreement; Other events Jul 31, 2026 8-K Results of operations (earnings release) Jul 29, 2026 8-K Amended charter or bylaws; Shareholder vote results May 20, 2026 8-K Results of operations (earnings release) May 13, 2026 10-Q Quarter ended 2026-03-31 May 13, 2026 8-K Entered a material agreement; Other events Apr 6, 2026 8-K Other events Apr 2, 2026 8-K Results of operations (earnings release) Mar 12, 2026 10-K Fiscal year ended 2025-12-31 Mar 12, 2026 8-K Entered a material agreement; Modified rights of security holders Jan 27, 2026 8-K Regulation FD disclosure; Other events Dec 29, 2025 8-K Entered a material agreement; Other events Nov 12, 2025 8-K Results of operations (earnings release) Nov 10, 2025 10-Q Quarter ended 2025-09-30 Nov 10, 2025 8-K Results of operations (earnings release) Aug 12, 2025 10-Q Quarter ended 2025-06-30 Aug 12, 2025 8-K Entered a material agreement; Other events Jul 7, 2025 8-K Shareholder vote results May 22, 2025 8-K Results of operations (earnings release) May 13, 2025 10-Q Quarter ended 2025-03-31 May 13, 2025 8-K Results of operations (earnings release) Mar 18, 2025 10-K Fiscal year ended 2024-12-31 Mar 18, 2025 8-K Entered a material agreement; Other events Dec 16, 2024 8-K Results of operations (earnings release) Nov 14, 2024 10-Q Quarter ended 2024-09-30 Nov 14, 2024 8-K Entered a material agreement Aug 13, 2024 8-K Results of operations (earnings release) Aug 8, 2024 10-Q Quarter ended 2024-06-30 Aug 8, 2024 8-K Director or officer change; Shareholder vote results May 28, 2024 8-K Results of operations (earnings release) May 13, 2024 10-Q Quarter ended 2024-03-31 May 13, 2024 8-K Entered a material agreement; Other events Apr 17, 2024 10-K Fiscal year ended 2023-12-31 Mar 6, 2024 8-K Amended charter or bylaws Jan 25, 2024 8-K Shareholder vote results Jan 12, 2024 8-K Results of operations (earnings release) Nov 9, 2023 10-Q Quarter ended 2023-09-30 Nov 9, 2023 8-K Delisting notice or listing-rule failure Nov 2, 2023 8-K Regulation FD disclosure; Other events Oct 10, 2023 8-K Results of operations (earnings release) Aug 9, 2023